{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:49:45Z","timestamp":1792853385148,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018201","name":"Syndax Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018201","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Blood Cancer United","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P01 CA108671"],"award-info":[{"award-number":["P01 CA108671"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007737","name":"St. Jude Children's Research Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ccell.2026.06.008","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:54:10Z","timestamp":1783608850000},"page":"1639-1652.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Menin-dependent megakaryocyte proliferation and fibrosis in myeloproliferative neoplasms"],"prefix":"10.1016","volume":"44","author":[{"given":"Jeremy","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anitria","family":"Cotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashid","family":"Mehmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trent","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber L.","family":"Broadhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunusa","family":"Olufadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guolian","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Marcellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Mascarenhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Janke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Gurbuxani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard M.","family":"McGeehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8182-8306","authenticated-orcid":false,"given":"John D.","family":"Crispino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2026.06.008_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ajh.26857","article-title":"Primary myelofibrosis: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Tefferi","year":"2023","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ccell.2026.06.008_bib2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.hoc.2020.11.004","article-title":"The Role of Megakaryocytes in Myelofibrosis","volume":"35","author":"Melo-Cardenas","year":"2021","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.ccell.2026.06.008_bib3","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00277-020-04002-9","article-title":"Management of myelofibrosis after ruxolitinib failure","volume":"99","author":"Harrison","year":"2020","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.ccell.2026.06.008_bib4","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1038\/s41467-025-60019-6","article-title":"Efficacy of JAK1\/2 inhibition in murine myeloproliferative neoplasms is not mediated by targeting oncogenic signaling","volume":"16","author":"Gorantla","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2026.06.008_bib5","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1158\/1078-0432.CCR-18-4089","article-title":"Activation of JAK\/STAT Signaling in Megakaryocytes Sustains Myeloproliferation In Vivo","volume":"25","author":"Woods","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2026.06.008_bib6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cell.2012.06.032","article-title":"Identification of Regulators of Polyploidization Presents Therapeutic Targets for Treatment of AMKL","volume":"150","author":"Wen","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2026.06.008_bib7","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/nm.3995","article-title":"Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition","volume":"21","author":"Wen","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2026.06.008_bib8","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1158\/1078-0432.CCR-19-1005","article-title":"Aurora Kinase A Inhibition Provides Clinical Benefit, Normalizes Megakaryocytes, and Reduces Bone Marrow Fibrosis in Patients with Myelofibrosis: A Phase I Trial","volume":"25","author":"Gangat","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2026.06.008_bib9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/MOH.0000000000000796","article-title":"The future of HOXA- expressing leukemias: Menin inhibitor response and resistance","volume":"31","author":"Wenge","year":"2024","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.ccell.2026.06.008_bib10","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1182\/blood-2012-05-429274","article-title":"Structural insights into inhibition of the bivalent menin-MLL interaction by small molecules in leukemia","volume":"120","author":"Shi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2026.06.008_bib11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nchembio.773","article-title":"Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia","volume":"8","author":"Grembecka","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ccell.2026.06.008_bib12","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ccell.2019.11.001","article-title":"A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia","volume":"36","author":"Krivtsov","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2026.06.008_bib13","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41586-023-05812-3","article-title":"The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia","volume":"615","author":"Issa","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2026.06.008_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1200\/JCO.24.00826","article-title":"Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)","volume":"43","author":"Issa","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ccell.2026.06.008_bib15","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1182\/blood.2025028357","article-title":"Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study","volume":"146","author":"Arellano","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2026.06.008_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13059-016-0939-7","article-title":"Single-cell profiling of human megakaryocyte-erythroid progenitors identifies distinct megakaryocyte and erythroid differentiation pathways","volume":"17","author":"Psaila","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.ccell.2026.06.008_bib17","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1182\/blood-2016-09-741611","article-title":"Identification of unipotent megakaryocyte progenitors in human hematopoiesis","volume":"129","author":"Miyawaki","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2026.06.008_bib18","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.molcel.2020.04.008","article-title":"Single-Cell Analyses Reveal Megakaryocyte-Biased Hematopoiesis in Myelofibrosis and Identify Mutant Clone-Specific Targets","volume":"78","author":"Psaila","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2026.06.008_bib19","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1182\/blood-2006-02-002030","article-title":"JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis","volume":"108","author":"Lacout","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2026.06.008_bib20","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ccr.2010.05.015","article-title":"Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells","volume":"17","author":"Mullally","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2026.06.008_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030270","article-title":"MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia","volume":"3","author":"Pikman","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.ccell.2026.06.008_bib22","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1038\/s41375-022-01684-0","article-title":"A CRISPR\/Cas9 engineered Mpl(S504N) mouse model recapitulates human myelofibrosis","volume":"36","author":"Adriaanse","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.ccell.2026.06.008_bib23","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1158\/2159-8290.CD-20-1652","article-title":"A Humanized Animal Model Predicts Clonal Evolution and Therapeutic Vulnerabilities in Myeloproliferative Neoplasms","volume":"11","author":"Celik","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2026.06.008_bib24","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1182\/blood-2008-01-135012","article-title":"Menin regulates the function of hematopoietic stem cells and lymphoid progenitors","volume":"113","author":"Maillard","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2026.06.008_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151584","article-title":"Meis1 Is Required for Adult Mouse Erythropoiesis, Megakaryopoiesis and Hematopoietic Stem Cell Expansion","volume":"11","author":"Miller","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ccell.2026.06.008_bib26","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1182\/blood-2008-07-167577","article-title":"Mef2C is a lineage-restricted target of Scl\/Tal1 and regulates megakaryopoiesis and B-cell homeostasis","volume":"113","author":"Gekas","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2026.06.008_bib27","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1182\/blood-2006-12-064626","article-title":"Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis","volume":"110","author":"Ciurea","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2026.06.008_bib28","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI82905","article-title":"Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosis","volume":"127","author":"Gilles","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ccell.2026.06.008_bib29","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/sj.leu.2401608","article-title":"Establishment and characterization of a new human megakaryoblastic cell line (SET-2) that spontaneously matures to megakaryocytes and produces platelet-like particles","volume":"14","author":"Uozumi","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.ccell.2026.06.008_bib30","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0925-4773(03)00039-X","article-title":"Genetic ablation of the tumor suppressor menin causes lethality at mid-gestation with defects in multiple organs","volume":"120","author":"Bertolino","year":"2003","journal-title":"Mech. Dev."},{"key":"10.1016\/j.ccell.2026.06.008_bib31","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1073\/pnas.0510347103","article-title":"The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression","volume":"103","author":"Chen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2026.06.008_bib32","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2014.106567","article-title":"MEIS1 regulates early erythroid and megakaryocytic cell fate","volume":"99","author":"Zeddies","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.ccell.2026.06.008_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ajh.27659","article-title":"Emerging Pathogenetic Mechanisms and New Drugs for Anemia in Myelofibrosis and Myelodysplastic Syndromes","volume":"100","author":"Gangat","year":"2025","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ccell.2026.06.008_bib34","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1038\/s41598-019-40896-w","article-title":"CRIS.py: A Versatile and High-throughput Analysis Program for CRISPR-based Genome Editing","volume":"9","author":"Connelly","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ccell.2026.06.008_bib35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1158\/2643-3230.BCD-24-0342","article-title":"Single-cell Transcriptional Atlas of Human Hematopoiesis Reveals Genetic and Hierarchy-Based Determinants of Aberrant AML Differentiation","volume":"6","author":"Zeng","year":"2025","journal-title":"Blood Cancer Discov."},{"key":"10.1016\/j.ccell.2026.06.008_bib36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. Roy. Stat. Soc. B Stat. Methodol."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610826002953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610826002953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T16:20:14Z","timestamp":1786378814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610826002953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1535610826002953"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2026.06.008","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Menin-dependent megakaryocyte proliferation and fibrosis in myeloproliferative neoplasms","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2026.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}